|
PER3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.37610000961308E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.68100003203631E-09 |
| Normal-vs-Stage2 |
3.69300000002681E-06 |
| Normal-vs-Stage3 |
1.984850E-03 |
| Normal-vs-Stage4 |
2.2993000003968E-07 |
| Stage1-vs-Stage2 |
6.168800E-01 |
| Stage1-vs-Stage3 |
3.183400E-01 |
| Stage1-vs-Stage4 |
3.962500E-02 |
| Stage2-vs-Stage3 |
2.565800E-01 |
| Stage2-vs-Stage4 |
2.420400E-01 |
| Stage3-vs-Stage4 |
3.367600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.2898020953005E-11 |
| Normal-vs-AfricanAmerican |
1.78299999997744E-06 |
| Normal-vs-Asian |
1.279660E-02 |
| Caucasian-vs-AfricanAmerican |
2.704200E-01 |
| Caucasian-vs-Asian |
7.742400E-01 |
| AfricanAmerican-vs-Asian |
5.148200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.88990001426248E-09 |
| Normal-vs-Female |
1.90419999999136E-05 |
| Male-vs-Female |
9.375200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.68720000004452E-06 |
| Normal-vs-Extreme_Weight |
1.48780000541748E-08 |
| Normal-vs-Obese |
8.14060000000616E-05 |
| Normal-vs-Extreme_Obese |
1.163540E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.734600E-01 |
| Normal_Weight-vs-Obese |
2.879600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.616000E-01 |
| Extreme_Weight-vs-Obese |
1.464150E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.716600E-01 |
| Obese-vs-Extreme_Obese |
8.515200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.193400E-04 |
| Normal-vs-Age(41-60Yrs) |
2.03179999999081E-05 |
| Normal-vs-Age(61-80Yrs) |
3.67419999980356E-07 |
| Normal-vs-Age(81-100Yrs) |
5.026000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.688600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.126400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.266000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.448260E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.431400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.971800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.49889997583352E-09 |
| Normal-VS-Type2 PRCC |
1.50570000001515E-06 |
| Normal-VS-KIRP CIMP |
2.111400000393E-07 |
| Normal-VS-Unclassified PRCC |
5.638000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
8.987200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.717500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.756800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.008300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.377200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.730300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.73819999999192E-06 |
| Normal-vs-N1 |
2.28619999999014E-05 |
| Normal-vs-N2 |
1.038530E-03 |
| N0-vs-N1 |
5.734400E-01 |
| N0-vs-N2 |
8.366100E-02 |
| N1-vs-N2 |
1.088220E-01 |
|
|
